The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes

International Journal of Clinical Pharmacy
Mangesh KharjulJames Green

Abstract

Background Adherence to treatment is important to achieve target outcomes, particularly for those with type 2 diabetes. Pharmacists are well placed to enhance adherence, however evidence of the impact on clinical outcomes is not well known. Objective To determine the impact of an adherence support service on adherence scores and subsequent clinical biomarkers (HbA1c). Setting Community pharmacies providing a Medicines Use Review (MUR) Service in a New Zealand locality. Methods Records of patients receiving MURs between 2007 and 2012 were obtained from a single locality. Data extraction included: individual characteristics, the adherence score assigned at every consultation, pathology records. Patients receiving oral hypoglycaemic medications (n = 86) were included in the final analysis using generalised estimating equations to explore change in HbA1c over time, and whether this was related to the adherence score. Main Outcome Measures (a) change in adherence scores and (b) association between adherence sores and HbA1c. Results A total of 350 records were obtained, of those, 115 of 350 people had follow up MUR visit/s and could be analysed for changes in adherence. Most people (110/115) showed sustained or improved adherence sco...Continue Reading

References

Feb 9, 2002·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A LieblA Goertz
Jun 29, 2004·Diabetes Care·David E GoldsteinDavid B Sacks
Nov 25, 2004·Diabetes Care·Manel PladevallJennifer Elston Lafata
Dec 28, 2005·The American Journal of Medicine·Wilson Y S LeungJuliana C N Chan
Oct 2, 2007·Diabetes Research and Clinical Practice·Kai-Jen TienMing-Chia Hsieh
Feb 21, 2009·Nature Clinical Practice. Endocrinology & Metabolism·Kay-Tee Khaw
Feb 2, 2010·Diabetes Research and Clinical Practice·Garry WelchRobert A Gabbay
Mar 11, 2011·Mayo Clinic Proceedings·Marie T Brown, Jennifer K Bussell
Apr 19, 2013·British Journal of Clinical Pharmacology·Ernieda HatahStephen B Duffull
Jul 23, 2013·Patient Preference and Adherence·Jacqueline G HugtenburgLiset van Dijk
Oct 29, 2013·Research in Social & Administrative Pharmacy : RSAP·Edwin C K TanJohnson George
Jul 8, 2015·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Amanda Harrop
Feb 24, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Mubashra ButtNorlaila Mustafa
Jun 2, 2016·Journal of Diabetes Research·Shamala AyaduraiSiti Norlina Md Said

❮ Previous
Next ❯

Citations

Apr 22, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Pooja LagisettyMichele Heisler
Mar 17, 2020·Journal of Primary Health Care·Mangesh D KharjulRhiannon Braund
Aug 21, 2020·Journal of Pharmacy Practice·Hanlin LiDemetra Tsapepas
Oct 1, 2020·International Journal of Clinical Pharmacy·Nuria García-Agua SolerFrancisco Jódar-Sánchez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.